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Background: Various DNA manipulation methods have been developed to prepare mutant genes for protein
engineering. However, development of more efficient and convenient method is still demanded. Homologous
DNA assembly methods, which do not depend on restriction enzymes, have been used as convenient tools for
cloning and have been applied to site-directed mutagenesis recently. This study describes an optimized
homologous DNA assembly method, termed as multiple patch cloning (MUPAC), for multiple site-directed and
saturation mutagenesis.
Results: To demonstrate MUPAC, we introduced five back mutations to a mutant green fluorescent protein (GFPuv)
with five deleterious mutations at specific sites and transformed Escherichia coli (E. coli) with the plasmids obtained.
We observed that the over 90% of resulting colonies possessed the plasmids containing the reverted GFPuv gene
and exhibited fluorescence. We extended the test to introduce up to nine mutations in Moloney Murine Leukemia
Virus reverse transcriptase (M-MLV RT) by assembling 11 DNA fragments using MUPAC. Analysis of the cloned
plasmid by electrophoresis and DNA sequencing revealed that approximately 30% of colonies had the objective
mutant M-MLV RT gene. Furthermore, we also utilized this method to prepare a library of mutant GFPuv genes
containing saturation mutations at five specific sites, and we found that MUPAC successfully introduced NNK
codons at all five sites, whereas other site remained intact.
Conclusions: MUPAC could efficiently introduce various mutations at multiple specific sites within a gene.
Furthermore, it could facilitate the preparation of experimental gene materials important to molecular and synthetic
biology research.Background
Site-directed and saturation mutagenesis are widely used to
prepare mutant genes for studying a protein function in
basic research and for preparation of engineered proteins
for industrial and pharmaceutical applications. For example,
protein function is studied by comparing the wild-type pro-
tein with the corresponding mutant proteins produced
from genes with single or multiple mutations. Site-directed
saturation mutagenesis combined with directed evolu-
tion strategies were also used to modify protein proper-
ties [1-4], such as altering substrate specificity [5-7],
enhancing activity [8-11], or improving thermal stability
[12,13]. To facilitate the preparation of mutant genes, vari-
ous methods of multiple site-directed and saturation mu-
tagenesis have been developed.* Correspondence: murah@bio.c.u-tokyo.ac.jp
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reproduction in any medium, provided the orThe most commonly used method for site-directed
mutagenesis is the QuikChange® method (Stratagene, La
Jolla, CA, USA), which employs mutagenic plasmid
amplification to introduce single site-directed muta-
tions. Using a more complicated protocol, this method
was extended to introduce up to five site-directed muta-
tions, although the complete mutagenesis efficiency
decreased to 32% [14]. To improve this efficiency,
OmniChange was developed and was used to success-
fully introduce five site-directed saturation mutations
[15]. Although this method demonstrated high effi-
ciency for complete multiple mutagenesis, synthesis of
phosphorothioate nucleotides is necessary to generate
3′-overhanging DNA fragments.
Since 1990, several homologous DNA assembly
methods [16-21] have been developed; one method in
particular, one-step isothermal in vitro recombination
(the ISO method) [20], was used to introduce multipleral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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multichange isothermal in vitro recombination (the
MISO method), multiple DNA fragments were first pre-
pared using polymerase chain reaction (PCR) followed
by gel purification. The DNA fragments possess 40-base
pair (bp) sequences homologous to the adjacent DNA
fragments on either side. Because the ISO reaction em-
ploys T5 exonuclease, DNA fragments are degraded in
a 5′–3′ direction, exposing a 3′ overhanging sequence
complementary to the adjacent DNA fragment. The
DNA fragments are annealed, and the gaps are filled
using Phusion DNA polymerase, and the resulting
nicks are sealed by Taq DNA ligase. This method per-
mits highly efficient assembly of up to six DNA frag-
ments and is used to successfully introduce eight point
mutations in a gene. However, because the ISO method
was originally generated to assemble DNA fragments
several hundred kilobases in length, the reaction condi-
tion was not necessary suitable for multiple site-
directed mutagenesis.
In this study, we developed an optimized DNA assembly
method, termed multiple patch cloning (MUPAC), which
could assemble up to 11 DNA fragments to introduce
nine site-directed mutations (Figure 1). The MUPAC reac-
tion mixture is easily prepared from commercially avail-
able common enzymes, including T5 exonuclease, Klenow
fragment (exo−), and T4 DNA ligase. We also utilized
MUPAC to introduce site-directed saturation mutations atFigure 1 Schematic illustration of the multiple patch cloning
procedure. DNA fragments are amplified by polymerase chain
reaction using two sets of oligo-DNA primers (shown in red and
blue). The star on the primer indicates the site of mismatch. The
resultant DNA fragments and digested vector DNA containing 16 bp
homologous regions (shown in yellow) were assembled at 37°C by
T5 exonuclease, Klenow fragment and T4 DNA ligase.multiple sites in GFPuv gene. Because MUPAC is a cost
effective and efficient method for the DNA manipulation,
this method would be a useful tool to prepare various mu-
tant genes to study and improve protein’s functions.
Results
Multiple patch cloning method
MUPAC is an optimized mutagenesis/cloning method
that allows the assembly of multiple dsDNA using short
16-bp assembly sequences (Figure 1). MUPAC employs
T5 exonuclease, Klenow fragment (exo−), and T4 DNA
ligase. In the reaction mixture, T5 exonuclease degraded
the DNA in a 5′–3′ direction and exposed 3′ overhang
in the assembly regions at the ends of each fragment.
When the DNA fragments annealed at the exposed
complementary single-strand region, Klenow fragment
(exo–) filled the gaps and T4 DNA ligase joined the nick
to assemble dsDNA. The difference between MUPAC
and the ISO method was the enzymes that were used
in the reaction mixture. Because the ISO method
employed thermostable DNA polymerase (Phusion DNA
polymerase) and DNA ligase (Taq DNA ligase) instead
of the Klenow fragment (exo−) and T4 DNA ligase, the
optimum temperature for the ISO reaction was 50°C
[20,22], which favored a long assembly sequence, typic-
ally 40 bp. When the method was applied to a multiple
site-directed mutagenesis in MISO, this feature became
drawback because the preparation of relatively long
oligo-DNAs was required to introduce each point muta-
tion. In contrast, MUPAC required an assembly se-
quence of only 16 bp because the optimal reaction
temperature for the enzymes used was 37°C. This differ-
ence also made it easy to prepare a saturation mutant
gene pool using short oligonucleotides as mentioned in
the section below.
GFPuv single site-directed mutagenesis
To evaluate the performance of new enzyme mixture in
a point mutagenesis, we first tested its ability to mutate
Tyr 66 in the mutant GFPuv to Asp. Because the Tyr 66
residue is key to the formation of the GFPuv chromo-
phore (Figure 2a), the mutation from Tyr to Asp abol-
ished fluorescence. Two PCR fragments were prepared
using wild-type GFPuv gene template and two sets of
PCR primers (1 and 2 in Additional file 1: Table S2), one
of which had a sequence that corresponded to the muta-
tion from the Tyr (TAT) codon to the Asp (GAT) codon.
The two fragments were assembled with the NheI–
EcoRI-digested pBAD plasmid using MUPAC, and the
colonies of the E. coli JM109 transformed by the assem-
bled plasmid were exposed to a UV light to observe
fluorescence. As expected, none of the colonies exhibited
fluorescence, indicating that no detectable wild-type
GFPuv gene persisted through MUPAC (Figure 2b vs. 2c).
Figure 2 Multiple site-directed mutagenesis of GFPuv. (a) Three-dimensional structure of GFP (PDB ID: 1GFL) depicted using the ribbon
model. Molecular graphics was created with the program UCSF Chimera (http://www.cgl.ucsf.edu/chimera/). The five residues, indicated by yellow
balls, were selected as mutation sites because each was essential for GFPuv fluorescence. (b) Wild-type GFPuv in the pBAD vector was used to
transform E. coli JM109. The tenth aliquot of each transformant was spread on the right half of an LB agar plate, and the remainder on the left
half. The percentage frequency of fluorescent colonies is indicated at the bottom left. (c) A point mutation (Y66D) was introduced in GFPuv by
MUPAC. One (d), three (e), or five (f) pre-introduced mutations were simultaneously restored to wild type by MUPAC. CFU in each experiment
are listed in Additional file 1: Table S3.
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gene to recover GFPuv fluorescence. Two PCR frag-
ments were prepared using mutant GFPuv Y66D tem-
plate and two sets of PCR primers (1 and 3 in
Additional file 1: Table S2), and were assembled with
the pBAD plasmid using MUPAC. As a result, 91% of
the colonies of the E. coli JM109 transformed by the as-
sembled plasmid exhibited fluorescence (Figure 2c vs.
2d). This result shows that a single mutation could be
introduced efficiently by MUPAC.
GFPuv multiple site-directed mutagenesis
Next, we evaluated the performance of MUPAC in mul-
tiple mutagenesis. For this experiment, we employed thesame back mutation strategy as for GFPuv single site di-
rected mutagenesis to confirm the complete back muta-
tion of mutant GFPuv genes. In addition to the Y66D
mutation, four other mutations (V29D, A110D, F165D,
and L201D) were chosen because the side chains of
these residues were oriented to the inside of the β-barrel
structure of GFPuv, and therefore only the one of the
mutations could disturb the fluorescent property of the
protein (data not shown). For three-point mutagenesis,
four PCR fragments were prepared using the V29D-
Y66D-A110D mutant (3D-mutant GFPuv) gene template
and four sets of PCR primers (4–7 in Additional file 1:
Table S2). Alternatively, for five-point mutagenesis, six
PCR fragments were prepared using the V29D-Y66D-
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template and six sets of PCR primers (4–6 and 8–10 in
Additional file 1: Table S2). These dsDNA fragments
were assembled in the NheI–EcoRI-digested pBAD plas-
mid using MUPAC, and fluorescent and non-fluorescent
colonies were counted to calculate the efficiency of
complete multiple mutagenesis. Contrary to our expec-
tations, the ratios of the fluorescent and non-fluorescent
colonies in three- or five- point mutagenesis (Figure 2e
and f) were similar to that in one point mutagenesis
(Figure 2d). Conversely, when MISO method was used
for five-point mutagenesis by assembling the same plas-
mid and PCR fragments, only 49% of colonies exhibited
fluorescence (Additional file 1: Figure S1). Moreover, the
numbers of colonies were similar between the one-
(3,240 colonies), three- (3,330 colonies), and five- (3,400
colonies) point mutagenesis by MUPAC. These results
clearly demonstrate the high fidelity and efficiency of
MUPAC for multiple site-directed mutagenesis.
Multiple site-directed mutagenesis of M-MLV RT gene
To evaluate the suitability of MUPAC for multiple site-
directed mutagenesis, we also attempted to introduce
six-point mutations (K69E, T147Q, D225P, F313W,
G435L, and K454N) in M-MLV RT gene in the pET16b
plasmid. Seven PCR fragments were prepared using the
M-MLV RT gene template and seven sets of PCR
primers (11–17 in Additional file 1: Table S2; Figure 3a),
assembled with NdeI–XhoI-digested pET16b plasmid
using MUPAC, and transformed into E. coli JM109. Gel
electrophoresis of NdeI–XhoI-digested plasmids ex-
tracted from the resulting colonies showed that 11 of
16 plasmids possessed full-length M-MLV RT gene
(Figure 3a). The DNA sequence analysis of the full-length
plasmid also showed that the all the genes sequenced had
all six mutations without undesired mutations.
Next, we increased the number of mutation sites from
six to nine (K69E, T147Q, D225P, F313W, N374I,
G435L, K454N, N524D, and T605V). Ten PCR frag-
ments were prepared using the M-MLV RT gene tem-
plate and ten sets of PCR primers (11–14, 16, and 18–22
in Additional file 1: Table S2; Figure 3b) were assembled
with the NdeI–XhoI-digested pET16b plasmid using
MUPAC, and transformed into E. coli JM109. Gel elec-
trophoresis of the NdeI–XhoI-digested plasmids showed
that 17 of 40 plasmids possessed full-length M-MLV
RT gene (Figure 3b, Additional file 1: Figure S2). DNA
sequence analysis of the plasmids also showed that all
full-length genes had all nine mutations without un-
desired mutation.
Although the proportion of plasmids possessing the
full-length mutant gene decreased as the number of
mutation sites increased, MUPAC still produced the
desired gene with nine-point mutations in approxi-mately 40% of plasmids (Figure 3c). These results clearly
demonstrate the suitability of MUPAC for multiple site-
directed mutagenesis.
Multiple site-directed saturation mutagenesis on GFPuv
gene
A number of studies have shown that the site-directed
saturation mutagenesis is useful for altering or improv-
ing a protein function [1-13]. Therefore, we tested the
performance of MUPAC in five-point site-directed satur-
ation mutagenesis (V29X, Y66X, A110X, F165X, and
L201X; X represents one of the 20 proteinogenic amino
acids) of GFPuv gene. Six PCR fragments, each of them
bearing NNK codon at the desired site, were prepared
using GFPuv gene and six sets of PCR primers (4, 23–27
in Additional file 1: Table S2; Figure 4a). The resulting
dsDNA fragments were assembled in an NheI–EcoRI-
digested pBAD plasmid using MUPAC, and trans-
formed into E. coli DH10B by electroporation. Sequence
analysis of the plasmid mixture extracted from >104 of
the resulting colonies showed that the extracted genes
contained random NNK codons at the desired sites
(Figure 4a and Additional file 1: Figure S3). We also in-
dependently sequenced 24 plasmids extracted from 24
randomly chosen colonies with GFPuv gene as an insert
(Additional file 1: Table S4). The sequence data showed
that all plasmids had mutations only at the desired sites.
At each mutation site, the codons exhibited A, T, G, or
C as the first and second bases, and T or G as the third
base (Figure 4b), and an average of 13 amino acid varia-
tions (including stop codon) was found at each site of
the NNK codon (Figure 4c). These results demonstrate
the suitability of MUPAC for the preparation of a gene
pool with multiple site-directed saturated mutations.
Discussion
We developed a DNA assembly method, termed
MUPAC, capable of assembling multiple dsDNAs with
short homologous sequences (Figure 1). Unlike the ISO
method, MUPAC uses DNA modification enzymes with
an optimum reaction temperature of 37°C. This feature
allows the use of short (e.g., 16 bp) homologous assem-
bly sequences, and confers high assembly efficiency.
We first used MUPAC for the back mutation of
fluorescence-deficient mutant GFPuv with one-, three-,
or five-site mutations (in which the original residue was
replaced by Asp). In all cases, approximately 90% of the
resulting colonies exhibited GFPuv fluorescence, which
demonstrates a high fidelity of MUPAC for multiple
site-directed mutagenesis (Figure 2d, e, f ). This result
also demonstrated the high efficiency of MUPAC be-
cause the similar numbers of colonies were obtained
for one-, three-, or five-point site-directed mutagenesis
of GFPuv.
Figure 3 Multiple site-directed mutagenesis of a M-MLV RT gene. Schematic presentation of six- (a) or nine-point (b) simultaneous mutation
in M-MLV RT gene is shown. DNA fragments amplified by PCR were assembled with the NdeI–XhoI-digested pET16b vector using MUPAC.
Length in base pair is shown over each DNA fragment. Plasmids were extracted from each six- and nine-point site-directed mutagenesis
experiment. After digestion with NdeI and XhoI, the digested plasmids were analyzed using 1.2% agarose gel electrophoresis (lanes 2–17, the
six-site experiments; lanes 19–34, the nine-site experiment). Lane 1 and 18 contain 1000 bp DNA ladder marker. CFU in each experiment are
listed in Additional file 1: Table S3. (c) Summary of 6- or 9-points mutation. Mutants were analyzed using electrophoresis and DNA sequencing.
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we extracted plasmids from the four non-fluorescent
colonies formed in the five-point site-directed mutagenesis
experiment, and we analyzed them using electrophoresis
and DNA sequencing (Additional file 1: Figure S4).
One contained a single nucleotide deletion in the pri-
mer region, indicating that impurity of the synthesized
primer caused the production of an undesired product.
The other three plasmids showed higher mobility than
the pBAD-NXE plasmid on electrophoresis analysis,
suggesting that the over-degradation of the plasmid
with T5 exonuclease caused the production of the un-
desired small plasmid.
We also found that the concentration of T5 exonucle-
ase, Klenow fragment exo − and T4 DNA ligase influ-
enced the efficiency of DNA assembly (Additional file 1:Figures S5 and S6). For efficient DNA assembly, at least
0.1 U/μL of T5 exonuclease was required. Assembly effi-
ciency was influenced to a lesser degree by the concen-
tration of Klenow fragment exo–, although the excess of
the Klenow fragment exo– caused a significant reduction
in the number of colonies carrying the desired plasmid.
Higher (2×) concentration of T4 DNA ligase did not
alter the assembly efficiency (520 colonies and 530
colonies), but slight reduction in the number of colonies
was observed when the concentration was reduced to
half the concentration (440 colonies; Additional file 1:
Figure S6).
To demonstrate the suitability of MUPAC for multiple
site-directed mutagenesis, we performed six- and nine-
point site-directed mutagenesis of M-MLV RT gene.
Analysis by electrophoresis showed that the 11 of 16 (for
Figure 4 Site-directed saturation mutagenesis using MUPAC. (a) DNA sequence chromatogram obtained by sequencing a plasmid mixture
from >104 clones. NNK codons, where K represents G or T were simultaneously introduced to the GFPuv gene at the five specific sites by using
MUPAC. CFU for the experiment is indicated in Additional file 1: Table S3. (b) Distribution of nucleotide bases in the five randomized codons.
Twenty-four plasmids obtained from individual clones in the saturation mutagenesis experiment were sequenced. The distribution of nucleotides
is shown in pie diagrams for each of the randomized base. The nucleotide base A is depicted in green, T in red, G in black, and C in blue.
(c) Amino acids appeared at the five sites. Twenty-four plasmids obtained from individual clones in the saturation mutagenesis experiment were
sequenced. Translated amino acids at the five sites are shown in one-letter style, and stop codon is denoted by asterisk.
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genesis) plasmids possessed full-length M-MLV RT gene
as an insert (Figure 3). Sequence analysis of the plasmids
containing the full-length gene showed that all the plas-
mids analyzed had all, six or nine, desired mutations.
In contrast with GFPuv mutagenesis, pET16b plasmid
was found in 2 of 16 colonies (for six-point mutagenesis)
and 19 of 40 colonies (for nine-point mutagenesis) in
M-MLV RT mutagenesis. Similar results were obtained
between experiments using different lots of restriction
enzyme-digested pET16b (Figure 3b vs. Additional file 1:
Figure S2). We sequenced plasmids with truncated M-
MLV RT gene; all possessed a deleted sequence in the
same position (Additional file 1: Figure S7). This dele-
tion was generated by an undesired assembly with a 7-
bp homologous region. Because M-MLV RT gene has
128 of 7-bp, 30 of 8-bp, 15 of 9-bp, and 1 of 10-bp hom-
ologous regions (Additional file 1: Table S5), it is surpris-
ing that only one deleted sequence resulted from an
undesired assembly.
The increased proportion of undesired plasmids with
nine-point mutagenesis compared with six-point muta-
genesis suggests that the number of DNA fragments re-
quiring assembly is a limitation of MUPAC. Similarly,
when MUPAC was used to assemble eight DNA frag-
ments of M-MLV RT gene, one of which was 49-bp in
length, the proportion of the plasmids carrying the de-
sired sequence significantly decreased (data not shown).Because T5 exonuclease degrades the DNA in the 5′–3′
direction at the each end, short DNA fragments could
simply be decomposed before assembly. The shortest
DNA fragment we used in this experiment was 73 bp;
therefore, the lower limit of the DNA length could be
50–70 bp. Thus, when the distance between two muta-
tion sites is under 50 bp, we recommend using a pair of
overlapping forward and reverse primers, both of which
carry each mutation (Additional file 1: Figure S8a). This
is also applicable to mutations whose interval is as short
as 16 bp; when the distance between two mutation sites
is less than 16 bp, a longer primer with two mutations
should be used (Additional file 1: Figure S8b).
We also applied MUPAC in multiple site-directed sat-
uration mutagenesis. Five sites of GFPuv gene were
chosen to introduce an NNK codon, and the plasmids
extracted from the mutant gene pool were sequenced.
All genes contained mutations at the desired sites, and
no undesired mutations existed elsewhere (Figure 4a,
Additional file 1: Figure S3). N (A, T, G, or C) at the first
and second bases and K (T or G) at the third base of the
NNK codons were evident in all codons at the five de-
sired sites, although the G appeared more frequently
(Figure 4b). This bias toward G could be simply caused
by the quality of the random oligonucleotides purchased
from Operon Biotechnologies because a similar bias was
observed in different oligonucleotides purchased from
the same company (data not shown).
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We developed the MUPAC system that could efficiently
assemble multiple DNAs with a short homologous se-
quence. MUPAC successfully achieved one- to five-point
site-directed mutagenesis of the GFPuv, and six- or
nine-point site-directed mutagenesis of the M-MLV RT
gene. Furthermore, we demonstrated the suitability of
MUPAC for five-point site-directed saturation mutagen-
esis of the GFPuv gene. We have also used this method
for the simple cloning of a gene, and for construction of
a plasmid with tandemly arranged genes (unpublished
result). Because MUPAC can flexibly manipulate DNA
in a simple and efficient manner, this method could
greatly contribute toward research in many fields includ-
ing molecular and synthetic biology.
Methods
Plasmids
The plasmid pBAD-NXE was constructed by the insertion
of double-stranded DNA (dsDNA) between NheI and
EcoRI sites of pBAD-GFPuv (Bio-Rad, Hercules, CA) [23].
The DNA sequence between the NheI and EcoRI sites of
pBAD-NXE was 5′-ATTAA CTCGA GCTTA T -3′. Mu-
tant Moloney Murine Leukemia Virus reverse transcriptase
gene (M-MLV RT, Additional file 1: Figure S9) [24,25]
was purchased from Operon Biotechnologies (Alameda,
CA) and was cloned into pET16b (Novagen, Darmstadt,
Germany) between NdeI and XhoI sites to construct
pET16b-MMLVRT.
Site-directed multiple mutagenesis
The template plasmids (pBAD-GFPuv and pET16b-
MMLVRT) were digested with EcoRV (New England
Biolabs, Ipswich, MA) in the presence of alkaline phos-
phatase (CIP, New England Biolabs) in order to avoid
contamination with the original plasmid. Templates
were added to the PCR reaction mixture (20 μL, KOD
DNA polymerase; Toyobo, Tokyo, Japan) without purifi-
cation, and the DNA fragments were amplified by
PCR using the pairs of the forward and reverse primers
(Additional file 1: Tables S1 and S2). All DNA fragments
were purified by using a FastGene Gel/PCR Extraction
Kit (Nippon Gene, Toyama, Japan), and eluted with
20 μL of the elution buffer.
The plasmids pBAD-NXE and pET16b were digested
with NheI–EcoRI and NdeI–XhoI, respectively, in the
presence of CIP. The products were purified by using
the FastGene Gel/PCR Extraction Kit.
The MUPAC enzyme stock solution was prepared by
mixing 10 μL of T5 exonuclease (10 U/μL; New England
Biolabs), 1 μL of Klenow fragment exo– (5 U/μL; New
England Biolabs), 2.5 μL of T4 DNA ligase (400 U/μL;
New England Biolabs), and 11.5 μL of the storage buffer
(50 mM Tris–HCl pH 7.5, 100 mM NaCl, 1 mM DTT,0.1 mM EDTA, 50% Glycerol, and 0.1% Triton X-100).
The enzyme stock solution was stored at –20°C. The
MUPAC reagent (2×) was prepared just prior to use by
mixing 1 μL of the enzyme stock solution and 20 μL of
the reaction buffer (100 mM Tris–HCl pH 7.5, 20 mM
MgCl2, 20 mM DTT, 2 mM ATP, 0.5 mM dNTPs, and
0.02% BSA).
The MUPAC reaction mixture was prepared by mix-
ing the restriction enzyme-digested plasmid (0.2 μL),
PCR-amplified DNA (0.8 μL), and MUPAC reagent (2×;
1 μL). The mixture (2 μL; comprising 5 ng/μL of re-
striction enzyme-digested plasmid, 3–8 ng/μL DNA
fragments, 50 mM Tris–HCl pH 7.5, 10 mM MgCl2,
10 mM DTT, 1 mM ATP, 0.25 mM dNTPs, 0.01% BSA,
0.1 U/μL T5 exonuclease, 0.005 U/μL Klenow fragment
exo–, and 1 U/μL T4 DNA Ligase) was incubated at 37°C
for 30 min and used directly for chemical transformation
of E. coli JM109.
GFPuv fluorescence measurement
After the transformation, the solution was diluted with
LB medium and plated onto an LB agar plate containing
50 μg/mL ampicillin and 0.2% arabinose. After 16 h of
incubation at 37°C, GFPuv fluorescence was observed
through a Y48 filter (480 nm cutoff filter; HOYA, Tokyo,
Japan) under 365 nm UV light.
Analysis of mutant M-MLV RT genes
After transformation, the solution was diluted with LB
medium and plated onto an LB agar plate containing
50 μg/mL ampicillin. Plasmids were extracted from
2 mL of a solution containing JM109 transformants cul-
tured overnight at 37°C. The plasmids were digested
with NdeI and XhoI, and analyzed by agarose gel elec-
trophoresis. The DNA sequences of the plasmids were
determined using the dideoxyribonucleotide method.
Site-directed multiple saturation mutagenesis
The MUPAC reaction was performed using the same
procedure as mentioned above. Subsequently, the DNA
was purified by ethanol precipitation, and used to trans-
form E. coli DH10B by electroporation. Plasmids were
extracted from 2 mL of a solution containing DH10B
transformants cultured overnight, and the DNA se-
quences were determined by the dideoxyribonucleotide
method. Alternatively, a DNA sequence chromatogram
was obtained from the mixture of the plasmids extracted
from all colonies (> 104) on an LB agar plate.
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